Editorial Response to Hepato-Biliary Disease Resection for Patients with Advanced Epithelial Ovarian Cancer: Prognostic Role and Optimal Cytoreduction

被引：0
|
作者：
Lee, Sarah S. [1 ]
Pothuri, Bhavana [1 ]
机构：
[1] NYU, Dept Obstet & Gynecol, Div Gynecol Oncol, Perlmutter Canc Ctr,Grossman Sch Med, New York, NY 10016 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2021年 / 28卷 / 01期
关键词：
D O I：
10.1245/s10434-020-09030-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：16 / 17
页数：2
相关论文
共 50 条
  • [31] Investigating the time intervals between primary cytoreductive surgery and initiation of adjuvant chemotherapy in patients with advanced epithelial ovarian cancer who had optimal cytoreduction surgery with bowel resection
    Lee, Y.
    Lee, J. W.
    Paik, E. S.
    Clark, M.
    Kim, R. S.
    Brown, T.
    May, T.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 98 - 98
  • [32] CLINICOPATHOLOGICAL BACKGROUND AND PROGNOSIS OF ADVANCED OVARIAN CANCER PATIENTS WITHOUT OPTIMAL CYTOREDUCTION AT PRIMARY SURGERY
    Saotome, K.
    Nomura, H.
    Dozen, A.
    Nanki, Y.
    Yoshihama, T.
    Iwasa, N.
    Chiyoda, T.
    Yamagami, W.
    Kataoka, F.
    Hirasawa, A.
    Aoki, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 828 - 828
  • [33] Role of Serum CA125 and HE4 in Predicting Optimal Cytoreduction in Advanced Epithelial Ovarian Cancer After Neoadjuvant Chemotherapy
    Poddar, Pabashi
    Patel, Shilpa
    Arora, Ruchi
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2023, 21 (03)
  • [34] Weekly induction intraperitoneal chemotherapy after primary surgical cytoreduction in patients with advanced epithelial ovarian cancer
    Zang R.Y.
    Li Z.T.
    Tang J.
    Huang X.
    Cai S.M.
    World Journal of Surgical Oncology, 4 (1)
  • [35] Bowel resection at the time of primary cytoreduction improves disease-free survival in epithelial ovarian cancer patients and is associated with acceptable morbidity
    Estes, JM
    Leath, CA
    Straughn, JM
    Kirbry, TO
    Huh, WK
    Kilgore, LC
    Barnes, MN
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2004, 199 (03) : S88 - S88
  • [36] Role of Serum CA125 and HE4 in Predicting Optimal Cytoreduction in Advanced Epithelial Ovarian Cancer After Neoadjuvant Chemotherapy
    Pabashi Poddar
    Shilpa Patel
    Ruchi Arora
    Indian Journal of Gynecologic Oncology, 2023, 21
  • [37] Impact of an early time to initiate chemotherapy on survival for patients with complete cytoreduction for advanced epithelial ovarian cancer
    Eisenkop, S. M.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 113 - 113
  • [38] PROGNOSTIC IMPLICATIONS OF LARGE VOLUME RESIDUAL DISEASE IN PATIENTS WITH ADVANCED STAGE EPITHELIAL OVARIAN-CANCER
    GALLION, HH
    VANNAGELL, JR
    DONALDSON, ES
    HANSON, MB
    KRYSCIO, RJ
    GYNECOLOGIC ONCOLOGY, 1987, 27 (02) : 220 - 225
  • [39] The prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced stage epithelial ovarian cancer
    Kolev, V.
    Mironov, S.
    Mironov, O.
    Moskowitz, C.
    Ishill, N. M.
    Gardner, G. J.
    Levine, D. A.
    Hricak, H.
    Barakat, R. R.
    Chi, D. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [40] A multicenter validation of computerized tomography models as predictors of non-optimal primary cytoreduction of advanced epithelial ovarian cancer
    Gemer, O.
    Gdalevich, M.
    Ravid, M.
    Piura, B.
    Rabinovich, A.
    Gasper, T.
    Khashper, A.
    Voldarsky, M.
    Linov, L.
    Ben Shachar, I.
    Anteby, E. Y.
    Lavie, O.
    EJSO, 2009, 35 (10): : 1109 - 1112
12345